Pfizer Inc. (PFE)

27.96 -0.06 (-0.21%) USD  |  NYSE  |  Aug 28, 16:00
27.94 -0.02 (-0.07%) After-Hours: 20:00
More

Pfizer Cash and Short Term Investments (Quarterly) : 11.70B for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PFE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 11.70B
March 31, 2026 13.08B
December 31, 2025 13.60B
September 30, 2025 14.98B
June 30, 2025 13.25B
March 31, 2025 17.32B
December 31, 2024 20.48B
September 30, 2024 9.952B
June 30, 2024 7.10B
March 31, 2024 11.93B
December 31, 2023 12.69B
September 30, 2023 44.18B
June 30, 2023 44.78B
March 31, 2023 19.97B
December 31, 2022 22.73B
September 30, 2022 36.12B
June 30, 2022 33.30B
March 31, 2022 23.90B
December 31, 2021 31.07B
September 30, 2021 29.70B
June 30, 2021 21.70B
March 31, 2021 13.67B
December 31, 2020 12.22B
September 30, 2020 21.91B
June 30, 2020 22.79B
Date Value
March 31, 2020 10.35B
December 31, 2019 9.83B
September 30, 2019 9.087B
June 30, 2019 12.91B
March 31, 2019 11.62B
December 31, 2018 18.83B
September 30, 2018 17.24B
June 30, 2018 13.43B
March 31, 2018 11.42B
December 31, 2017 20.01B
September 30, 2017 16.92B
June 30, 2017 14.33B
March 31, 2017 14.56B
December 31, 2016 17.85B
September 30, 2016 14.37B
June 30, 2016 20.94B
March 31, 2016 19.44B
December 31, 2015 23.29B
September 30, 2015 20.66B
June 30, 2015 30.26B
March 31, 2015 27.71B
December 31, 2014 36.12B
September 30, 2014 33.45B
June 30, 2014 34.05B
March 31, 2014 33.88B

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Johnson & Johnson 20.76B
Eli Lilly & Co. 8.95B
Merck & Co., Inc. 7.182B
Bristol Myers Squibb Co. 11.07B
Viatris, Inc. 1.410B